Your search matched 13 results
The Institute for Clinical and Economic Review (ICER) has gained industry-wide notoriety for their cost effectiveness analyses, which typically investigate the value of available treatments within a specific disease state.
What do CBD, digital health and “femtech” all have in common?
Drug makers aren’t the only ones under pressure for high costs.
Do you love that LaLa feeling?
Employers wield enormous influence in deciding the care their employees receive – yet they aren’t always considered a core “stakeholder” in the healthcare debate.
Everyone seems to be talking about digital health, but what does that really look like in action?
In case you haven’t heard, it’s the New Year.
You may have seen a lot of recent reporting on “loss of coverage” for Americans.
There’s a lot to be learned from Boeing’s reputational challenges – and their early efforts to start rebuilding trust among pilots, flight attendants and customers.
The anti-vaccination movement is causing challenges not just in healthcare, but now in tech.
As the industry awaits a potential executive order on transparency around healthcare costs, we took a look at some transparency tools, and where they’re falling short.
AI is to 2019 what blockchain was to 2018.
Prescription delivery services – like Hims, Roman and Kick – are popping up all over the place, prompting concerns about regulation.